Provided by Tiger Trade Technology Pte. Ltd.

Fidelity MSCI Health Care Index ETF

83.77
+0.65500.79%
Volume:85.73K
Turnover:7.19M
Market Cap:3.52B
PE:- -
High:84.48
Open:83.42
Low:83.42
Close:83.11
52wk High:85.46
52wk Low:64.30
Shares:42.00M
Float Shares:42.00M
Volume Ratio:0.75
T/O Rate:0.20%
Dividend:1.02
Dividend Rate:1.21%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

FDA Greenlights Roche and Eli Lilly's Blood-Based Alzheimer's Test, Setting a Single Threshold to Rule Both In and Out Amyloid Pathology

Deep News
·
Aug 25

Moderna Inc Stock (MRNA) Moved Up by 10.02% on Aug 25: Drivers Behind the Movement

TradingKey
·
Aug 25

Merck Price Target Raised to $170.00/Share from $145.00 by Argus Research

Dow Jones
·
Aug 25

China's Shandong Xinhua Profit Drops on Domestic, International Competition

Reuters
·
Aug 25

China's Innovent Biologics H1 Revenue, Profit Rise on Strong Product Sales

Reuters
·
Aug 25

Austar Lifesciences H1 Profit Drops on Higher R&D Spending

Reuters
·
Aug 25

WuXi Biologics H1 Net Profit up on Margin Expansion

Reuters
·
Aug 25

Stick with Value Stocks Until Everyone Starts Talking About Them - and as of Now They're Still Under the Radar, This Wall Street Firm Says

Dow Jones
·
Aug 25

Merck & Company (MRK) Gets a Buy from Scotiabank

TIPRANKS
·
Aug 25

Merck price target raised to $170 from $145 at Argus

TIPRANKS
·
Aug 25

Parabilis Medicines Appoints Former J&J Oncology Executive Craig Tendler to Board

Reuters
·
Aug 25

Merck price target raised to $180 from $155 at Wolfe Research

TIPRANKS
·
Aug 25

Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX) and Eli Lilly & Co (LLY)

TIPRANKS
·
Aug 25

Terragen Posts Wider Loss as Revenue Falls and Asset Backing Erodes

TIPRANKS
·
Aug 25

Molecular Partners H1 Net Loss Narrows on Lower R&D Expenses

Reuters
·
Aug 25

SEC Joins National Project for Next-Generation Radiotherapy System

TIPRANKS
·
Aug 25

BetterLife Pharma Plans Equity Offering to Advance Neurological Trial Program

TIPRANKS
·
Aug 25

Merck (MRK) Stock May Be 35% Undervalued After Cancer Vaccine Data

Simply Wall St.
·
Aug 25

US FDA Expands Approval for J&J's Drug for Rare Blood Disorder

Reuters
·
Aug 25

FDA Approves J&J Imaavy for Warm Autoimmune Hemolytic Anemia Treatment

Reuters
·
Aug 25